Alopecia Market
                     Alopecia Market To 
Reach USD 12.99 
Billion By 2026
www.reportsanddata.com
Market Summary
Rising incidences of chronic disorders such as hyperthyroidism, acute stress disorder 
hypopituitarism, hypothyroidism, and lupus are the major factors influencing market growth.
Market Size – USD 8.64 billion in 2018, Market Growth - CAGR of 5.1%, Market Trends –Increase in 
disposable income coupled with rising concern about aesthetic appearance
The Alopecia Market is expected to reach USD 12.99 Billion by 2026, according to a new report by 
Reports and Data. This can be mainly associated with rising predominance of chronic disorders such 
as hyperthyroidism, hypothyroidism, acute stress disorder, lupus, and hypo pituitarism. Moreover, 
increasing incidence of Hodgkin’s disease, Hashimoto’s disease, Addison’s disease, and celiac disease 
along with factors such as access to quick treatment are expected to drive the market growth. 
However, high cost of treatment and adverse side effects is expected to restrain the growth. Also, 
changing lifestyle such as consumption of tobacco, an increase in the use of alcohol, and other 
associated products, growing stress levels, and the expanding population are expected to spur the 
market. Increasing disposable incomes coupled with the expanding emphasis on aesthetic 
appearance are also likely to add to the demand for alopecia treatment worldwide.
www.reportsanddata.com
Market Summary
The rising number of introduction of new drugs, consumer disposable incomes, and the complementary 
initiatives taken by the relevant organizations namely, AHLA and NAAF, are the crucial factors for the North 
America region to account for the largest market share of 22.30% in 2018.
Hair loss, also acknowledged as alopecia or baldness refers to a loss of hair from part of the head. The typical 
pattern of hair loss can vary from a small area to the entire body. Scarring or inflammation is not present. Hair 
loss in some people may cause psychological distress. General types include female-pattern hair loss, male-
pattern hair loss, alopecia areata, and a thinning of hair also known as telogen effluvium. The cause of male-
pattern hair loss is a combination of male hormones and genetics, the purpose of female pattern hair loss is 
not clear, the use of alopecia areata is auto-immune, and the cause of telogen effluvium is mostly a 
psychologically or physically stressful event.
Avail the inside scoop of the Sample report @ 
https://www.reportsanddata.com/sample-enquiry-form/1334
www.reportsanddata.com
Market Summary
Further key findings from the report suggest
• Alopecia areata is an autoimmune skin disease identified by the hair loss on the scalp, face, and other 
areas of the body. Alopecia areata is segmented into totalis, patchy, and universalis further.
• Increasing predominance coupled with rising awareness regarding aesthetic appeal and physical 
appearance is also assumed to drive the growth in the next few years.
• Androgenetic type accounts for the largest market share of 42.20% in 2018 and is estimated to reach USD 
5.51 billion by 2026.
• Also, the availability of treatments such as oral treatments, licensed topical treatments involving the use of 
finasteride and minoxidil; and surgical procedures such as hair replacement and transplantation are 
expected to drive the market.
Click here to avail the report at discount rate: 
https://www.reportsanddata.com/discount-enquiry-form/1334
www.reportsanddata.com
Market Summary
Key participants include Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun 
Pharmaceutical Industries Ltd., Merck & Co., Inc., Cirrus Hair Centers, Lexington International 
LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.
For the purpose of this study, Reports and Data have segmented the global Alopecia Market on the basis of 
Disease, Gender, application, Sales distribution and region:
Disease Outlook (Revenue, USD Million; 2016-2026)
• Alopecia Areata
• Androgenetic Alopecia
• Others
Sales distribution Outlook (Revenue, USD Million; 2016-2026)
• Prescriptions
• OTC
To read the full report now, with industry-wide coverage, visit: 
https://www.reportsanddata.com/checkout-form/1334
www.reportsanddata.com
Market Summary
Application Outlook (Revenue, USD Million; 2016-2026)
• Homecare Settings
• Dermatology Clinics
Gender Outlook (Revenue, USD Million; 2016-2026)
• Female
• Male
Regional Outlook (Revenue, USD Million; 2016-2026)
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
www.reportsanddata.com
About Us
Reports and Data is a market research and 
consulting company that provides syndicated research 
reports, customized research reports, and consulting 
services. Our solutions purely focus on your purpose to 
locate, target and analyze consumer behavior shifts 
across demographics, across industries and help client’s 
make a smarter business decision. 
Contact US
We offer market intelligence studies ensuring relevant 
and fact-based research across a multiple industries John Watson
including Healthcare, Technology, Chemicals, Power, and Head of Business Development
Energy. We consistently update our research offerings to 
ensure our clients are aware about the latest trends Reports And Data | Web: 
existent in the market. Reports and Data has a strong www.reportsanddata.com
base of experienced analysts from varied areas of Direct Line: +1-212-710-1370
expertise. E-mail: [email protected]
www.reportsanddata.com